Ziwei Song

Ziwei Song

Auto-generated profile, based on publicly available information

Ziwei Song

Department of Epidemiology, Milken Institute School of Public Health, The George Washington University, Washington, DC, United States

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 December 2023 in Cancer Research Communications
Verified
Journal Article
Open access
PDF file
RHRaymond W. Hughley
Raymond W. Hughley
MMMarco Matejcic
Marco Matejcic
ZSZiwei Song
Ziwei Song
XSXin Sheng
Xin Sheng
PWPeggy Wan
Peggy Wan
CHChristopher A. Haiman
Christopher A. Haiman
Prostate cancer risk is influenced by rare and common germline variants. We examined the aggregate association of rare germline pathogenic/likely pathogenic/deleterious (P/LP/D) variants in ATM, BRCA2, PALB2, and NBN with a polygenic risk score (PRS) on prostate cancer risk among 1,796 prostate cancer cases (222 metastatic) and 1,424 controls of African ancestry. Relative to P/LP/D non-carriers at average genetic risk (33%–66% of PRS), men with low (0%–33%) and high (66%–100%) PRS had Odds Ratios (ORs) for overall prostate cancer of 2.08 [95% confidence interval (CI) = 0.58–7.49] and 18.06 (95% CI = 4.24–76.84) among P/LP/D carriers and 0.57 (95% CI = 0.46–0.71) and 3.02 (95% CI = 2.53–3.60) among non-carriers, respectively. The OR for metastatic prostate cancer was 2.73 (95% CI = 0.24–30.54) and 28.99 (95% CI = 4.39–191.43) among P/LP/D carriers and 0.54 (95% CI = 0.31–0.95) and 3.22 (95% CI = 2.20–4.73) among non-carriers, for men with low and high PRS, respectively. Lifetime absolute risks of overall prostate cancer increased with PRS (low to high) from 9.8% to 51.5% in P/LP/D carriers and 5.5% to 23.9% in non-carriers. Lifetime absolute risks of metastatic prostate cancer increased with PRS from 1.9% to 18.1% in P/LP/D carriers and 0.3% to 2.2% in non-carriers These findings suggest that assessment of prostate cancer risk for rare variant carriers should include PRS status. Significance: These findings highlight the importance of considering rare and common variants to comprehensively assess prostate cancer risk in men of African ancestry.

13 June 2024 in Environmental Research
Verified
Journal Article
Closed access
ZSZiwei Song
Ziwei Song
KLKatie Lynch
Katie Lynch
NPNaa Adoley Parker-Allotey
Naa Adoley Parker-Allotey
EBErin E. Bennett
Erin E. Bennett
Xiaohui XuXiaohui Xu
Xiaohui Xu
MPMelinda C. Power
Melinda C. Power